Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Access Pharma revealed plans for a China clinical trial...
A TCM, Fuzheng Huayu capsules, will begain a Phase...
Jiangsu Hengrui Medicine received FDA approval to begin...
Sinovac Biotech...
The Shanghai Institute of Biological Sciences (SIBS) has...
Four China life science companies have completed very...
Boehringer Ingelheim will invest $149 million in China...
Novartis made a five-year, $1 billion China commitment,...
PPD, Inc. will acquire BioDuro, a preclinical CRO, as a...
Merck Serono will build a $250 million global R&D center...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
